Browse All

Current Filters

CLEAR FILTER x

TITLE

Author Institution:

Sleep, Physical Activity and Incident Amyotrophic Lateral Sclerosis: A Large Prospective Cohort Study of Over 500,000 Participants

Author:Li, Hongfu   Xie, Jiali   

Session Name:S2: Updates on Motor Neuron and Peripheral Nerve Disorders  

Topic:Neuromuscular and Clinical Neurophysiology (EMG)  

Program Number:S2.006  

Author Institution:Second Affiliated Hospital, Zhejiang University School of Medicine, Zhejiang, China, People's Republic of  

Safety and Efficacy of Riliprubart, an Activated C1s-complement Inhibitor in CIDP: 76-week Phase Two Trial Results

Author:Querol, Luis   Lewis, Richard A.   Hartung, Hans-Peter   van Doorn, Pieter A.   Lin, Jie   Dionne, Annie   Attarian, Shahram   Wallstroem, Erik   Auwarter, Kristen   Lu, Yi   Alonso-Alonso, Miguel   Atassi, Nazem   Hughes, Richard A. C.   

Session Name:S2: Updates on Motor Neuron and Peripheral Nerve Disorders  

Topic:Neuromuscular and Clinical Neurophysiology (EMG)  

Program Number:S2.008  

Author Institution:Neuromuscular Diseases Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain  Centro para la Investigación Biomédica en Red en Enfermedades Raras (CIBERER), Madrid, Spain, Spain  Department of Neurology, Cedars Sinai Medical Center, Los Angeles, CA, USA, CA  Department of Neurology, Faculty of Medicine, Heinrich-Heine-University, Düsseldorf, Germany  Brain and Mind Center, University of Sydney, Sydney, NSW, Australia  Department of Neurology, Medical University of Vienna, Vienna, Austria  Department of Neurology, Palacky University Olomouc, Olomouc, The Czech Republic, Dusseldorf, Germany  Erasmus MC, University Medical Center, Rotterdam, The Netherlands, Netherlands  Department of Neurology and Rare Disease Center, Huashan Hospital, Fudan University, Shanghai, China, Shanghai, China, People's Republic of  CHU de Quebec Universite Laval, Quebec, Canada, QC, Canada  Neuromuscular Disease and ALS Reference Center, Timone University Hospital, Aix-Marseille University, CHU Timone, Marseille Cedex 05, France, France  Sanofi R&D, Neurology Development, Cambridge, MA, USA, Cambridge, MA  Sanofi, USA, MA  Sanofi R&D, Biostatistics and Programming, Cambridge, MA, USA, CA  Sanofi R&D, Neurology Development, Cambridge, MA, USA, MA  UCL Queen Square Institute of Neurology, University College London, London, UK, United Kingdom  

Efficacy and Safety of Subcutaneous Self-administered Gefurulimab in Generalized Myasthenia Gravis: Primary Results From the Phase Three, Randomized, Double-blind, Placebo-controlled PREVAIL Study

Author:Gwathmey, Kelly   Sacca, Francesco   Howard, James   Vu, Tuan   Xi, Jianying   Maurer, Mathias   Ruck, Tobias   Young Shin, Ha   Takahashi, Masanori   Casasnovas, Carlos   Smilowski, Marek   Peric, Stojan   Masuda, Masayuki   Scholz, Joachim   Shang, Shulian   Yee, Min   Rakhade, Sanjay   Annane, Djillali   

Session Name:S14: Updates on Myasthenia Gravis  

Topic:Neuromuscular and Clinical Neurophysiology (EMG)  

Program Number:S14.006  

Author Institution:Virginia Commonwealth University, Richmond, VA  University of Naples Federico II, Napoli, Italy  University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC  University of South Florida Morsani College of Medicine, Tampa, FL  Huashan Hospital, Fudan University, Shanghai, China, People's Republic of  Würzburg-Mitte Hospital, Würzburg, Germany  Ruhr University Bochum, BG University Hospital Bergmannsheil, Bochum, Germany  Yonsei University College of Medicine, Seoul, Korea, Republic of  The University of Osaka Graduate School of Medicine, Osaka, Japan  Bellvitge University Hospital, Barcelona, Spain  Medical University of Silesia, Katowice, Poland  Clinical Center of Serbia, University of Belgrade, Belgrade, Serbia  Tokyo Medical University, Tokyo, Japan  Alexion AstraZeneca Rare Disease, Boston, MA  Hôpital Raymond Poincaré, Garches, France  

Efficacy and Safety of Efgartigimod in Anti-acetylcholine Receptor Antibody–Negative Generalized Myasthenia Gravis: Initial Results of ADAPT SERON

Author:Howard, James   Vu, Tuan   Zhao, Chongbo   Luo, Sushan   Hoffmann, Sarah   Claeys, Kristl   Jimenez, Rosa   Seghers, Ineke   Masschaele, Delphine   Huang, Wan-Yi   Rzepinski, Lukasz   Chroni, Elisabeth   Alshehri, Ali Mohammed   Breiner, Ari   

Session Name:S14: Updates on Myasthenia Gravis  

Topic:Neuromuscular and Clinical Neurophysiology (EMG)  

Program Number:S14.008  

Author Institution:The University of North Carolina, NC  University of South Florida Morsani College of Medicine, FL  Huashan Hospital, Fudan University, China, People's Republic of  Charité – Universitätsmedizin Berlin, Germany  University Hospitals Leuven  and KU Leuven, Belgium  argenx, Belgium  10th Military Research Hospital and Polyclinic  and University of Science and Technology, Poland  University Hospital of Patras, Greece  King Faisal Specialist Hospital and Research Centre, Saudi Arabia  The Ottawa Hospital/The University of Ottawa, ON, Canada  

Prolonged Vegetative State in Anti-NMDA Receptor Encephalitis: Complications, Outcomes, and Implications

Author:Guasp, Mar   Simabukuro, Mateus   Muñoz-Sánchez, Guillermo   Brenner, Juliette   Wurdack, Katharina   Wang, Kang   LaLive, Patrice   Olivé, Gemma   Yeung, Jonas   Wandinger, Klaus Peter   Macher, Stefan   Di Liberto, Giovanni   Lancaster, Eric   Casadevall, Teresa   Martínez-González, María Jesús   Fernández-Carrasco, Juan Pablo   Shibata, Mamoru   Fukao, Eri   Mishima, Takayasu   Nakagawa, Hiroto   Takizawa, Tsubasa   Shimohama, Sho   Izawa, Yoshikane   Neshige, Shuichiro   Borràs, Roger   Aguilar, Esther   Marmolejo Alcaide, Laura   Planaguma, Jesus   Heller, Ariel   Tojima, Maya   Ikeda, Akio   Blanco Morgado, Yolanda   Du Pasquier, Renaud   Sühs, Wolfram   Leypoldt, Frank   Hoeftberger, Romana   Finke, Carsten   Titulaer, Maarten   Armangue, Thais   Graus, Francesc   Iizuka, Takahiro   Dalmau, Josep   

Session Name:S30: Autoimmune Neurology: Clinical CNS Autoimmune and Inflammatory Disorders  

Topic:Autoimmune Neurology  

Program Number:S30.004  

Author Institution:Hospital Clínic Barcelona - IDIBAPS, Barcelona, Spain  Hospital Das Clinicas, Sao Paulo U Scho of Med, Sao Paulo, Brazil  Hospital Clínic Barcelona , Barcelona, Spain  Erasmus University Medical Center, Rotterdam, Netherlands  Department of Neurology, Charité Universitätsmedizin Berlin, Berlin, Germany  Department of Neurology, the First Affiliated Hospital, School of Medicine, Zhejiang University, China, People's Republic of  University Hospital of Geneva, Geneva, Switzerland  Neuroimmunology Program, IDIBAPS, Barcelona, Spain  Alice Ho Miu Ling Nethersole Hospital, Hong Kong, Hong Kong  Institute of Clinical Chemistry, University Hospital Schleswig-Holstein Lübeck, Lübeck, Germany  Medical University of Vienna, Vienna, Austria  Lausanne University Hospital (CHUV) and University of Lausanne, Lausanne, Switzerland  The University of Pennsylvania, Dept. of Neurology, Philadelphia, PA  Hospital Comarcal Sant Jaume de Calella, Spain  Cruces University Hospital, Biobizkaia Health Research Institute, Spain  Hospital Carlos Van Buren de Valparaíso, Universidad de Valparaíso, Chile  Tokyo Dental College Ichikawa General Hospital, Japan  Showa General Hospital, Tokyo, Japan  Sakura Medical Center, Toho University, Sakura, Japan  Kagoshima City Medical Association Hospital, Kagoshima, Japan  Keio University School of Medicine, Tokyo, Japan  Hiroshima University Graduate School of Biomedical and Health Sciences, Japan  IDIBAPS, Spain  Children's Hospital of Pittsburgh/University of Pittsburgh Medical Center, Pittsburgh, PA  Kyoto University Hospital, Japan  Kyoto University Hospital, Kyoto, Japan  Hospital Clínic Barcelona, Barcelona, Spain  Service of neurology, CHUV, Lausanne, Switzerland  Hannover Medical School, Germany  University Hospital Schleswig-Holstein, Campus Kiel Department of Neurology, Kiel, Germany  Medical University of Vienna, Wien, Austria  Charité Berlin, Berlin, Germany  Erasmus Medical Center, Rotterdam, Netherlands  IDIBAPS-HClinic, Barcelona, Spain  IDIBAPS, Barcelona, Spain  Department of Neurology, Kitasato University School of Medicine, Sagamihara, Japan